NCT04886271 2026-04-15Recombinant Humanized Anti-CD47 / PD-1 Bifunctional Antibody HX009 Injection in the Treatment of Advanced Solid TumorsHangzhou Hanx Biopharmaceuticals, Ltd.Phase 2 Completed20 enrolled